基本信息
views: 4
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
He is widely respected for pharmacokinetics studies of anticancer drugs in the brain and cerebrospinal fluid, experimental and clinical studies of chemotherapy during radiation therapy, chemotherapy regimens for the treatment of gliomas, and studies of chemotherapy and radiation therapy for childhood medulloblastoma and ependymoma. He has had developed combination chemotherapy and chemoradiation treatments that reflected translation from laboratory to clinic that were successful in clinical trials and investigation. His most recent laboratory research efforts were to develop novel cell-based 2-dimensional and 3-dimensional assays to speed the development of new combinations that selectively inhibit signal transduction pathways critical to tumor proliferation.
Specialties: 1. Development of drug combinations and unique therapies for patients with cancer in the nervous system.
2. Translational research leading to understanding chemotherapy action and practice in cancer trials, especially central nervous system neoplasms.
3. Multidisciplinary program development and team building.
4. Development of IND primary brain tumor protocols for FDA submission.
Research Interests
Papers共 509 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Load More
Author Statistics
#Papers: 508
#Citation: 30404
H-Index: 91
G-Index: 157
Sociability: 8
Diversity: 1
Activity: 0
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn